Golden Biotechnology Corporation (TPEX:4132)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
3.470
0.00 (0.00%)
Apr 9, 2026, 2:59 PM CST

Golden Biotechnology Company Description

Golden Biotechnology Corporation operates as a drug discovery and healthy food supplement manufacturing company in Taiwan, the United States, Japan, China, Korea, and Singapore.

Its products include Liverty that is used for liver health support and fatigue; Rasle, an auto-immune adjuvant therapy; ZSAINO, a nourishment product for recovery from illness and for health improvement; and UMOOZE, a herbal formula for optimal health in males.

The company also provides Antroquinonol, an anticancer molecule for the treatment of pancreatic cancer, acute myeloid leukemia, and hepatocellular carcinoma, as well as hypercholesterolemia and hyperlipidemia.

The company was founded in 2002 and is headquartered in New Taipei City, Taiwan.

Golden Biotechnology Corporation
Country Taiwan
Founded 2002
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
CEO Wenjian Cai

Contact Details

Address:
No. 27-6, Zhongzheng East. Road
New Taipei City
Taiwan
Phone 886 2 2808 6006

Stock Details

Ticker Symbol 4132
Exchange Taipei Exchange
Fiscal Year January - December
Reporting Currency TWD
ISIN Number TW0004132006
SIC Code 2836

Key Executives

Name Position
Sheng Yong Liu Founder and Chairman of the Board
Wenjian Cai GM and President
Eric Lin Chief Financial Officer
Dr. YL Tai Ph.D. Chief Scientific Officer
Jun Hua Lian Treasurer